7LWE

Crystal structure of the BCL6 BTB domain in complex with OICR-7629

7LWE の概要

• エントリーDOI: 10.2210/pdb7lwe/pdb
• 分子名称: B-cell lymphoma 6 protein, N-(3-chloropyridin-4-yl)-2-(3-methyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetamide, FORMIC ACID, ... (6 entities in total)
• 機能のキーワード: immunity, inflammatory response, transcription repressor, transcription-inhibitor complex, transcription/inhibitor
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 15319.46

構造登録者

Kuntz, D.A.,Prive, G.G. (登録日: 2021-03-01, 公開日: 2022-03-09, 最終更新日: 2023-10-25)

• 主引用文献: Mamai, A.,Chau, A.M.,Wilson, B.J.,Watson, I.D.,Joseph, B.B.,Subramanian, P.R.,Morshed, M.M.,Morin, J.A.,Prakesch, M.A.,Lu, T.,Connolly, P.,Kuntz, D.A.,Pomroy, N.C.,Poda, G.,Nguyen, K.,Marcellus, R.,Strathdee, G.,Theriault, B.,Subramaniam, R.,Mohammed, M.,Abibi, A.,Chan, M.,Winston, J.,Kiyota, T.,Undzys, E.,Aman, A.,Austin, N.,Du Jardin, M.,Packman, K.,Phillippar, U.,Attar, R.,Edwards, J.,O'Meara, J.,Uehling, D.E.,Al-Awar, R.,Prive, G.G.,Isaac, M.B.; Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.; Acs Med.Chem.Lett., 14:199-210, 2023; PubMed: 36793435; DOI: 10.1021/acsmedchemlett.2c00502

実験手法

X-RAY DIFFRACTION (1.17 Å)